Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
New considerations in the assessment of aortic stenosis
Lucy M Safi1, Jonathan J Passeri2, Michael H Picard3
1Director of Interventional Echocardiography, Hackensack University Medical Center, Hackensack, NJ 07601, USA.
Insights
Calcific aortic stenosis (AS) is a common heart valve disease. Future assessment will integrate advanced imaging, biomarkers, and genetics for better patient risk stratification.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Medical Diagnostics
Background:
- Calcific aortic stenosis (AS) is a prevalent acquired valvular heart disease in industrialized nations.
- The aging population is increasing the prevalence of AS.
- Current preventative medications for AS have proven unsuccessful.
Purpose of the Study:
- To explore advancements in identifying and risk-assessing patients with calcific aortic stenosis.
- To discuss the evolving landscape of AS assessment beyond traditional echocardiography.
Main Methods:
- Utilizing Doppler echocardiography for initial stenosis severity classification.
- Investigating advanced imaging modalities for improved patient assessment.
- Exploring the role of serum biomarkers in risk stratification.
- Considering genetic assessment as a future diagnostic tool.
Main Results:
- Doppler echocardiography remains the standard for classifying stenosis severity.
- Research is ongoing to enhance patient identification and risk assessment.
- No current medications have been successful in preventing AS.
Conclusions:
- AS assessment is shifting from solely echocardiographic gradients to a multimodal approach.
- Future surveillance will incorporate advanced imaging, serum biomarkers, and genetic data.
- This transition aims for more precise patient management and risk stratification.
Abstract:
Calcific aortic stenosis (AS) is one of the most common acquired valvular heart diseases in industrialized nations. It is a slowly progressive disease and with the aging population, the prevalence of AS is expected to increase. Doppler echocardiography is used to classify patients based on severity of stenosis. Research efforts on how to better identify and risk-assess these patients are currently underway using advanced imaging modalities and serum biomarkers. Thus far, medications for AS prevention have been unsuccessful. As technology progresses, the assessment of AS will transition from one heavily weighed on echocardiographic gradients to one of active surveillances with multimodality imaging, serum biomarkers and genetic assessment.
More Related Videos
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
09:24O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
Aortic Regurgitation III: Medical Management